Abraham M, Gonen M, Kraus D. Complications of type 1 thyroplasty and arytenoid adduction. Laryngoscope 2001; 11:1322-329.
Amar D, Melendez JA, Zhang H, Dobres C, Leung DHY, Padilla RE. Correlation of peripheral venous-pressure and central venous-pressure in surgical patients. Journal of Cardiothoracic Vascular Anesthesia. 2001;15:40-43.
[PubMed Abstract]
Araten DJ, Swirsky D, Karadimi A, Notaro R, Nafa K, Bessler M, Thaler HT, Castro-Malaspina H, Childs BH, Boulad F: Cytogenetic and morphological abnormalities in paroxysmal-nocturnal hemoglobinuria. British Journal of Haematology 2001;115:360-368.
Bach AM, Hann LE, Hadar O, Shi W, Yoo HH, Giess CS, Sheinfeld J, Thaler H. Testicular microlithiasis What is its association with testicular cancer. Radiology 2001;220:70-75.
Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of COPD: a summary and appraisal of published evidence (Review). Ann Int Med 2001;134:600-620.
Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital procedure volume on survival following resection of lung cancer. New England Journal of Medicine 2001;345:181-188.
Bach, PB, Schrag D, Nierman DM, Horak D, White P, Young JW, Groeger JS. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001;98 3236-3242.
Ballangrud AM, Yang WH, Charlton DE, McDevitt MR, Hamacher KA, Panageas KS, Ma DS, Bander NH, Scheinberg DA, Sgouros G. Response of LNCaP spheroids following treatment with alpha-particle-emitter (213Bi)-labeled anti-PSMA antibody (J591), Cancer. Research. 2001;61:2008-2014.
[PubMed Abstract]
Begg CB. The search for Cancer. risk factors: when can we stop looking? (with commentaries) American Journal of Public Health. 2001;91:360-364.
[PubMed Abstract]
Begg CB. Commentary on "Two cheers for p-values", Journal of Epidemiology and Biostatistics 2001;6:206.
Berg WJ. Schwartz L. Yu R. Mazumdar M. Motzer RJ. Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma. Investigational New Drugs. 19(4):317-20, 2001.
Berwick M, Song YS, Jordan R, Brady MS, Orlow I. Mutagen sensitivity as an indicator of soft tissue sarcoma risk. Environmental and Molecular Mutagenesis 2001:38:223-226 .
Berwick M, Matullo G, Vineis P. DNA repair as a biomarker. IN Wilson S, Suk, W. Technology-Driven Biomarker Development Application in Environmentally-Associated Diseases. CRC Press, 2002
Bilsky MH, Boland PJ, Panageas KS, Woodruff JM, Brennan MF, Healey JH. Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patients, Neurosurgery, 2001;49:1277-1286.
Bisogna M, Calvano JE, Ho GH, Orlow I, Cordon-Cardo C, Borgen PI, Van Zee KJ. Molecular analysis of the INK4A and INK4B gene loci in breast carcinoma. Cancer Genetics and Cytogenetics 2001;125:131-138.
Brooks AD, Bowne WB, Delgado R, Leung DHY, Woodruff J, Lewis JJ, Brennan MF. Soft-tissue sarcomas of the groin - diagnosis, management and prognosis. Journal of the American College of Surgeons 2001;193:130-136.
Busam K, Antonescu CR, Nehal KS, Marghoob A A, Sachs DL, Shiu J, Berwick M. Histologicclassification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma: a study of inter-observer agreement. American Journal of Clinical Pathology 2001; 115:856-60.
Byrne RR, Shariat SF, Brown R, Kattan MW, Morton Jr RA, Wheeler TM, Lerner SP. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ, and lymph node metastases with long term follow-up. Journal of Urology. 2001;165(5):1473.
[PubMed Abstract]
Carson SS, Bach PB. Predicting mortality in patients suffering from prolonged critical illness: an assessment of four severity-of-illness measures. Chest 2001;120:928-933.
Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: The International Union Against Cancer. survey. Cancer. 2001;91(7):1390-3.
[PubMed Abstract]
Cheung NKV, Kushner BH, Laquaglia M, Kramer K, Gollamud. S, Heller G, Gerald W, Yeh S, Finn R, Larson SM. N7 - a novel multimodality therapy of high-risk neuroblastoma (NB) in children diagnosed over 1 year of age. Medical Pediatric Oncology 2001;36:227-230.
Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecologic Oncology 2001;82:532-537.
Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum - a clinical comparison. Annals of Surgical Oncology 2001;8:290-299.
Cody HS, 3rd, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, Yeh SDJ, Borgen PI. Complementarity of blue-dye and isotope in sentinel node localization for breast Cancer.: univariate and multivariate analysis of 966 procedures. Annals of Surgical Oncology. 2001; 8:13-19.
[PubMed Abstract]
Coffey DC, Kutko MC, Glick RD, Butler LM, Heller G, Rifkind RA, Marks PA, Richon VM, LaQuagli MP. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in-vivo, alone with synergistically with all-trans-retinoic acid. Cancer Research. 2001; 61:3591-3594.
[PubMed Abstract]
Conlon KC, Labow D, Leung D, Smith A, Jarnagin W, Coit DG, Merchant N, Brennan MF. Prospective randomized clinical trial of the value of intraperiotoneal drainage after pancreatic resection. Annals of Surgical Oncology 2001;234:487-493.
Dellit TH, Armaslou B, Bosl GJ, Sepkowitz KA, Thaler H, Blaskovich J: A method for assessing house staff workload as a function of length of stay (letter). Journal of the American Medical Association 2001;286: 1023-1024.
Fokianos K, Kedem B, Qin J, Short DA. A semi-parametric approach to the one-way layout. Technometrics. 2001;43:56-65.
Fornier MN, Seidman AD, Theodoulou M, Moynahan ME, Currie V, Moasser M, Sklarin N, Gilewski T, DAndrea G, Salvaggio R, Panageas KS, Norton L, Hudis C. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma, Clinical Cancer Research, 2001; 7: 3934-3941.
Gasparro F, Berwick M, Mitchnick M, Diffey B, Nash J, Mitchel D, Young A, Knowland J, Seykora J, Brown D. Godar D. Sun protective agents: formulations, effects and side effects. IN Katz Fitzpatrick T, Dermatology in General Medicine, 6th Edition. , Medical Publishing Division, McGraw-Hill, New York
Gemignani ML, Alektiar KM, Leitao M, Mychalczak B, Chi D, Venkatraman E, Barakat RR, Curtin JP. Radical surgical resection and high-dose intraoperative radiation-therapy (HDR-IORT) in patients with recurrent gynecologic cancers. International Journal of Radiation Oncology 2001;50:687-694.
Gemignani ML, Hensley ML, Cohen R, Venkatraman ES, Saigo PE, Barakat RR. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecological Oncology. 2001;80:16-20.
[PubMed Abstract]
Gilewski T, Ragupathi G, Bhuta S, Williams LJ, Musselli C, Zhang XF, Bencsath KP, Panageas KS, Chin J, Hudis CA. Immunization of metastatic breast Cancer. patients with a fully synthetic globo H conjugate B A phase I trial. Proceedings of the National Academy of Sciences of U.S.A. 2001; 98:3270-3275.
[PubMed Abstract]
Gonen M, Panageas KS, Larson S. Statistical issues in the analysis of diagnostic imaging experiments with multiple observations per patient, Radiology, 2001;221:763-767.
Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. Pap smears in patients with endometrial carcinoma. Acta Cytologica 2001. 45: 555-560.
Harlap S, Olson SH, Akhmedkhanov A, Barakat RR, Caputo TA, Sanchez D, Xue X. Epithelial ovarian cancer and European birthplace of grandparents. Gynecologic Oncology 2001;81:25-32.
Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DHY, Gold JS, Woodruff JM, Lewis JJ, Brennan MF. Clinicopathological analysis of patients with adult rhabdomyosarcoma. Cancer. 2001; 91:794-803.
[PubMed Abstract]
Heath SC, Robledo R, Beggs W, Feola G, Parodo C, Rinaldi A, Contu L, Dana D, Stambolian D, Siniscalco M. A novel approach to search for Identiy By Descent in small samplings of patients and controls from the same Mendelian Breeding Unit. A pilot study on myopia. Human Heredity 2001;52:183-190.
Hedvat CV, Filippa, DA, Qin J, Jaffe ES, Cordon-Cardo C, Nimer SD, Feldstein JT. Macrophage-derived chemokine (MDC) is expressed by Reed-Sternberg cells in classical Hodgkin's disease: application of tissue microarrays. Modern Pathology 2001;14:1270-76.
Heller, G. and Qin, J. Pairwise rank based likelihood for estimation and inference on the mixture proportion. Biometrics 2001;57:813-817.
Heller G. An adjustment for a post-randomization variable in the comparison of two treatments for survival. Statistics in Medicine 2001;20:3475-3485.
Heller G. The Cox proportional hazards model with a partly linear relative risk function. Lifetime Data Analysis 2001;7:255-277.
Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Identification of risk-factors for requiring transfusion during front-line chemotherapy for ovarian cancer. Gynecologic Oncology 2001;81:485-489.
Hernando-Monge E*, Orlow I*, Liberal V, Nohales G, Benezra R, Cordon-Cardo, C. Molecular and functional analyses of the mitotic checkpoint components HSMAD2, HBUB1 and HBUB2 in human cancer. International Journal of Cancer 2001;95:223-227. *Both authors contributed equally to the work.
Hoos A, Urist MJ, Stojadinovic A, Mastorid S, Dudas ME, Leung DHY, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of Cancer. specimens using the example of human fibroblastic tumors. American Journal of Pathology. 2001;158:1245-1251.
[PubMed Abstract]
Hummer A, Yang S. On the extended log-rank estimating function for the censored regression model. Computational Statistics and Data Analysis 2001;37:171-180.
Hwu W-J, Raizer J, Panageas KS, Lis E. Treatment of metastatic melanoma in the brain with temozolomide and thalidomide, Lancet Oncology, 2001; 2: 634-635.
Jackson A, Skwarchuk MW, Zelefsky MJ, Cowen DM, Venkatraman ES, Levegrun S, Burman CM, Kutcher GJ, Fuks Z, Liebel SA. Late rectal bleeding after conformal radiotherapy of prostate cancer (II) - volume effects and dose-volume histograms. International Journal of Radiation Oncology 2001;49:685-698.
[PubMed Abstract]
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Bodniewicz J, Youssef M, Blumgart LH. Staging analysis of resectability and outcome on 225 patients with hilar cholangiocarcinoma. Annals of Surgery 2001; 234:507-519
Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. Journal of Urology 2001;166(1):63-67.
Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn PA, Cavanagh W, Leibel S, Scardino PT. Pretreatment nomogram for predicting freedom from recurrence following permanent prostate brachytherapy in prostate cancer. Urology 2001;58(3):393-399.
Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, Stockman J, Fong Y, Jarnagin W, Bertino J. A phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. Journal of Clinical Oncology 2001;19:2687-2695.
Kolesnick R, Fuks Z, Venkatraman E. Endothelial-cells and radiation gastrointestinal syndrome - response (editorial). Science 2001;294:1411.
Kothari P, Scardino P, Ohori M, Kattan MW, Wheeler T. Incidence, location and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer. American Journal of Surgical Pathology 2001; 25(11):1429-1432.
Kramer K, Kushner B, Heller G, Cheung NKV. Neuroblastoma metastatic to the central nervous system - the Memorial Sloan-Kettering Cancer Center experience and a literature review. Cancer 2001;91:1510-1519.
Kushner BH, Wolden S, LaQuaglia MP, Kramer K, Verbel D, Heller G, Cheung NKV. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. Journal of Clinical Oncology 2001;19:2821-2828.
[PubMed Abstract]
Leung DHY. Statistical methods for clinical studies in the presence of surrogate endpoints. Journal of the Royal Statistical Association A164:485-503.
Leung DHY, Wang YG. Isotonic designs for phase I trials. Controlled Clinical Trials. 2001;22:126-138.
Leung DHY, Wang YG. A Bayesian decision approach for sample size determination in phase II trials. Biometrics. 2001;57:309-312.
Leung DHY, Wang YG. Optimal designs for evaluating a series of treatments. Biometrics. 2001;57:168-171.
Levegrun S, Jackson A, Zelefsky MJ, Skwarchuk MW, Venkatraman ES, Schlegel W, Fuks Z, Leibel SA, Ling CC. Fitting tumor control probability models to biopsy outcome after 3 dimensional conformal radiation therapy of prostate cancer - pitfalls in deducing radiobiological parameters for tumors from clinical data. International Journal of Radiation Oncology 2001;51:1064-1080.
Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of esponse to salvage radiation therapy in patients with prostate Cancer. recurrence after radical prostatectomy. Journal of Clinical Oncology. 2001;19(4):1030-1039.
[PubMed Abstract]
Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Risk of endometrial carcinoma associated with BRCA mutation. Gynecological Oncology. 2001;80:395-398.
[PubMed Abstract]
Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic reviews of complementary therapies. Part 2: Herbal Medicine. BMC Complementary and Alternative Medicine 2001;1:5.
Linde K, Vickers A, Hondras M, ter Riet G, Thormaehlen J, Berman B, Melchart D. Systematic reviews of complementary therapies. Part 1: Acupuncture. BMC Complementary and Alternative Medicine 2001;1:3.
Mahabir S, Frenkel K, Coit D, Brady MS, Lewis JJ, Berwick M. The effects of vitamin E on DNA damage in cancer patients. Melanoma Research 2001; 11:1-8.
Makhija S, Leitao M, Sabbatini P, Bellin N, Almadrones L, Leon L, Spriggs DR, Barakat R. Complications associated with intraperitoneal chemotherapy catheters. Gynecologic Oncology. 2001;81:77-81.
[PubMed Abstract]
Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, Weigel TL, Kris MG, Venkatraman ES, Rusch VW. Morbidity and mortality after neoadjuvant therapy for lung cancer - the risks of right pneumonectomy. Annals of Thoracic Surgery 2001;72:1149-1154.
Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Human Pathology 2001; 32(8):828-833.
Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ. Predicting outcome of chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. Journal of Clinical Oncology. 2001;19:2534-2541.
[PubMed Abstract]
Mazumdar M, Fazzari M, Panageas KS. A standardization method to adjust for the effect of patient selection in phase II clinical trials. Statistics in Medicine. 2001;20:883-892.
[PubMed Abstract]
McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: A summary and appraisal of published evidence. Chest 2001;119:1190-1209.
Melendez J, Ferri E, Zwillman M, Fischer M, DeMatteo R, Leung D, Jarnagin W, Fong Y, Blumgart LH. Extended hepatic resection B A year retrospective study of risk factors for perioperative mortality. Journal of the American College of Surgeons. 2001:192:47-53.
[PubMed Abstract]
Miransky J, Ruo L, Nicollette S, Eagan J, Sepkowitz K, Margetson, N, Thaler H, Cohen AM, Guillem JG. Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection-rates. Diseases of the Colon and Rectum 2001;44:1100-1105.
Mora J, Cheung NKV, Chen LS, Qin J, Gerald W. Survival analysis of clinical, pathological, and genetic features in neuroblastoma presenting as locoregional disease. Cancer. 2001;91:435-442.
[PubMed Abstract]
Mora J, Gerald WL, Qin J, Cheung NK. Molecular genetics of neuroblastoma and the implications for clinical management: A review of the MSKCC experience. The Oncologist 2001;6:263-268.
Moskowitz CH, Nimer SD, Zelenetz AD, Trippett T, Hedrick EE, Filippa DA, Louie D, Gonzalez M, Walits J, Coady-Lyons N, Qin J, Frank R, Bertino J, Goy A, Noy A, O'Brien JP, Straus D, Portlock CS, Yahalom J. A two-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory hodgkin's disease: analysis by intent to treat and development of a prognostic model. Blood. 2001;97:616-623.
[PubMed Abstract]
Motwani M, Jung C, Sirotnak FM, She Y, Shah MA, Gonen M, Schwartz G. Augmentation of apoptosis and tumor regressions by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts. Clinical Cancer Research 2001; 7:4209-4219.
Offit K, Robson M, Schrag D. Prophylactic mastectomy in carriers of BRCA mutations (Letter). New England Journal of Medicine 2001;345:1498-1499.
Oliveria S, Dusza S, Berwick M. Issues in the epidemiology of melanoma. Expert Review in Anticancer Therapy 2001;1:453-459.
Oliveria SA, Christos PJ, Halpern AC. Skin cancer screening and prevention in the primary care setting: analysis of the National Ambulatory Medical Care Survey 1997. Journal of General Internal Medicine 2001;16:297-301.
Oliveria SA, Nehal KS, Christos PJ, Sharma N, Tromberg JS, Halpern AC. Using nurse practitioners for skin cancer screening. A pilot study. American Journal of Preventive Medicine 2001;21:214-217.
Olivier M, Aggarwal A, Almendras AJ, Bajorek ES, Beasley EM, Brady SD, Bushard JM, Bustos VI, Chu A, Chung TR, DeWitte A, Denys ME, Dominguez R, Fang NY, Foster BD, Freudenberg RW, Hadley D, Hamilton LR, Jeffrey TJ, Kelly L, Lazzeroni L, Levy MR, Lewis SC, Liu X, Lopez FJ, Louie B, Marquis JP, Martinez RA, Matsuura MK, Misherghi NS, Norton JA, Olshen A, Perkins SM, Perou AJ, Piercy C, Piercy M, Qin F, Reif T, Sheppard K, Shokoohi V, Smick GA, Sun WL, Stewart EA, Fernando J, Tejeda, Tran NM, Trejo T, Vo NT, Yan SC, Zierten DL, Zhao S, Sachidanandam R, Trask BJ, Myers RM, Cox DR. A high-resolution radiation hybrid map of the human genome draft sequence. Science 2001; 291: 1298-1302.
Olson SH. Reported participation in case-control studies: changes over time. American Journal of Epidemiology 2001;154:574-81.
Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer in cases and controls. Obstetrics and Gynecology 2001;98:212-7.
Orjuela M, Orlow I, Dudas M, Ridaura C, Leal L, Salazar A, Abramson D, Gerald W, and Cordon-Cardo C. Alterations of cell cycle regulators in non-familial retinoblastoma. Human Pathology 2001;32:537-544.
Orlow I, Roy P, Barz A, Canchola R, Song Y, Begg CB, Berwick M. Validation of a rapid detection method-denaturing high performance liquid chromatography (DHPLC) for the identification of human INK4A gene mutations. Journal of Molecular Diagnostics 2001; 3:158-163.
Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross J, Cordon-Cardo C (2000). HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. Clinical Cancer Research 2001;7:2643-2647.
Pierce AJ, Stark J, Araujo FP, Moynahan ME, Berwick M, Jasin M. Double-strand breaks and tumorigenesis. Trends in Cell Biology, 2001:11:S52-9.
Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW. Potency after permanent prostate brachytherapy for localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2001; 50(5):1235-1242.
Qin J, Wang MC. Semiparametric analysis of truncated data. Lifetime data analysis 2001;7:225-242.
Ramos CB, Erdi YE, Gonen M, Riedel E, Yeung HWD, Macapinlac HA, Chisin R, Larson SM. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. European Journal of Nuclear Medicine. 2001;28:155-164.
Robbins R, Tuttle M, Sharaf R, Larson S, Robbins H, Ghossein R, Smith A, Drucker W. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 2001; 86(2):619-25.
Ross PL, Scardino PT, Kattan MW. A catalog of prostate Cancer. nomograms. Journal of Urology. 2001;165(5):1562.
[PubMed Abstract]
Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS, Downey RJ, Ginsberg RJ. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Journal of Thoracic Surgery 2001;122:788-795.
Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB. The lifetime risks of breast Cancer. in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer. Epidemiology, Biomarkers and Prevention. 2001;10:467-473.
[PubMed Abstract]
Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? (with editorial) Journal of Clinical Oncology 2001;19:3712-3718.
Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. Journal of the National Cancer Institute 2001;93:850-857.
Seidman AD, Fornier M, Esteva FJ, Tan L, Kaptain S, Bach A, Panageas KS, Arroyo C, Valero VN, Currie V, Gilewski T, Theodoulou M, Moynahan ME, Moasser M, Sklarin N, Dickler M, Cristofanilli M, Rivera E, Hortobagyi G, Norton L, Hudis CA. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification, Journal of Clinical Oncology, 2001;19: 2587-2595.
Shariat SF, Andrews B, Kim J, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Preoperative plasma levels of transforming growth factor ß1 strongly predict clinical outcome in patients with bladder carcinoma. Cancer 2001; 92(12):2985-2992.
Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001; 58(6); 1008-1015.
Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM, Slawin KM. Preoperative plasma levels of transforming growth factor ß1 strongly predict progression in patients undergoing radical prostatectomy. Journal of Clinical Oncology 2001;19:2856-2864.
Shibata D, Lewis JJ, Leung DH, Brennan MF. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? Journal of the American College of Surgeons 2001;193:373-379.
Shmulewitz, D, Auerbach SB, Lehner T, Blundell ML, Winick JD, Youngman LD, Skilling V, Heath SC, Ott J, Stoffel M, Breslow JL, Friedman JM. Epidemiology and factor analysis of obesity, Type II diabetes, hypertension and dyslipidemia (syndrome X) on the island of Kosrae, Federated States of Micronesia. Human Heredity. 2001;51:8-19.
[PubMed Abstract]
Shmulewitz D. and Heath SC. Genome scans for Q1 and Q2 on general population replicates using Loki. Genetic Epidemiology 2001;21 Suppl 1:S686-691.
Sonoda Y, Zerbe M, Smith A, Lin O, Barakat R, Hoskins W. High Incidence of Positive Peritoneal Cytology in Low-Risk Endometrial Cancer. Treated by Laparoscopically-Assisted Vaginal Hysterectomy. Gynecologic Oncology. 2001; 80(3):378-82.
Stojadinovic A, Hoos A, Karpoff HM, Leung DHY, Antonescu CR, Brennan MF, Lewis JJ. Soft-tissue tumors of the abdominal wall B analysis of disease patterns and treatment. Archives of Surgery. 2001;136:70-79.
[PubMed Abstract]
Stojadinovic A, Jaques DP, Leung DHY, Healey JH, Brennan MF. Amputation for recurrent soft-tissue sarcoma of the extremity - indications and outcome. Annals of Surgical Oncology 2001;8:509-518.
Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study. BMC Medical Research Methodology 2001;1:6.
Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow-up measurements. British Medical Journal 2001;323:1123-1124.
Vickers AJ. Message to complementary and alternative medicine: evidence is a better f riend than power. BMC Complementary and Alternative Medicine. 2001, 1:1.
[PubMed Abstract]
Vicker AJ. Acupuncture for treatment of chronic neck pain: Reanalysis of data suggests that effect is not a placebo effect. British Medical Journal 2001;323:1306.
Vickers AJ. Time course of muscle soreness following different types of exercise. Biomet Central Musculoskletal Disorders 2001;2:5.
Vickers AJ. On breakfast and randomized trials. British Medical Journal. 2001;322:85.
Vickers AJ, Cassileth BR. A review of unconventional therapies used for treatment of Cancer. and Cancer.-related symptoms. Lancet Oncology. 2001;2:226-32.
Vuky J, Bains M, Bacik J, Higgins G, Bajorin DF, Mazumdar M, Bosl GJ, Motzer JR. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. Journal of Clinical Oncology. 2001;19:682-688.
[PubMed Abstract]
Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS. Ultraviolet A and melanoma: a review. Journal of the American Academy of Dermatology 2001; 44:837-46
Wang MC, Qin J. Chiang CT. Analyzing recurrent event data with informative censoring. Journal of the American Statistical Association 2001;96:1057-1065.
Wang ES, Straus DJ, Qin J, Teruyafe J, Noy A. Intensive chemotherapy (CODOX-M/IVAC) compares favorably with other regimens for HIV positive and negative patients with Burkitts lymphoma (BL) (Meeting Abstract). Blood. 2001;96:597.
Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DYH, Borgen PI, Cody HS. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast Cancer. patients with positive sentinel nodes. Annals of Surgery. 2001;8:145-149.
[PubMed Abstract]
Winawer SJ, Zauber AG. Colonoscopic polypectomy and the incidence of colorectal cancer. Gut. 2001; 48:753-754.
Xu S, Zalian K, Thaler H, Matei C, Alfieri A, Chen YC, Koutcher JA. Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity. International Journal of Radiation Oncology. 2001;49:1381-1390.
Yeung HWD, Cody HS, Turlakow A, Riedel ER, Fey J, Gonen M, Nunez R, Yeh SD, Larson SM. LSG and SNL at surgery in breast cancer patients: a comparison between one-day and two-day protocols. Journal of Nuclear Medicine 2001;42:420-423.
Zauber NP, Sabbath-Solitare M, Marotta SP, Zauber AG, Bishop DT. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. Journal of Pathology 2001;193:303-309.
Zauber AG, Winawer SJ. Screening colonoscopy. In Colorectal Cancer: a Clinical Guide to Therapy. Edited by H Bleiberg, N Kemeny, P Rougier, and H Wilke. Martin Dunitz Ltd, London, pp 39-45,2001.
Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA. High-dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer. Journal of Urology 2001;166:876-881.
